C

Caladrius Biosciences Inc
LSE:0HS8

Watchlist Manager
Caladrius Biosciences Inc
LSE:0HS8
Watchlist
Price: 2.58 USD -5.15%
Market Cap: 50m USD
Have any thoughts about
Caladrius Biosciences Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Caladrius Biosciences Inc

Current Assets 37.7m
Cash & Short-Term Investments 35.9m
Other Current Assets 1.8m
Non-Current Assets 507k
PP&E 278k
Intangibles 210k
Other Non-Current Assets 19k
Current Liabilities 4.7m
Accounts Payable 556k
Accrued Liabilities 4.1m
Non-Current Liabilities -182k
Other Non-Current Liabilities -182k

Balance Sheet
Caladrius Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
19
20
7
29
10
14
17
25
32
23
Cash Equivalents
19
20
7
29
10
14
17
25
32
23
Short-Term Investments
7
0
0
26
33
11
18
70
37
28
Total Receivables
3
3
0
0
0
0
0
0
0
0
Accounts Receivables
3
3
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
7
6
17
6
1
1
1
1
3
3
Total Current Assets
36
29
25
61
44
26
35
96
72
54
PP&E Net
16
17
1
0
0
1
1
1
1
0
PP&E Gross
16
17
0
0
0
1
1
1
1
0
Accumulated Depreciation
5
8
0
0
0
0
0
0
0
0
Intangible Assets
48
3
0
0
0
0
0
0
0
0
Goodwill
25
7
0
0
0
0
0
0
0
0
Other Long-Term Assets
1
1
28
2
0
0
0
0
0
0
Other Assets
25
7
0
0
0
0
0
0
0
0
Total Assets
126
N/A
57
-55%
54
-6%
63
+19%
45
-30%
27
-39%
36
+32%
97
+169%
73
-25%
55
-25%
Liabilities
Accounts Payable
6
4
2
1
1
2
1
2
3
2
Accrued Liabilities
4
6
3
8
5
5
3
3
4
4
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
5
4
0
0
0
0
0
0
0
Other Current Liabilities
4
5
13
0
0
0
0
0
0
0
Total Current Liabilities
16
21
21
9
6
6
4
5
6
7
Long-Term Debt
15
11
3
0
0
0
0
0
0
0
Deferred Income Tax
18
1
0
0
0
0
0
0
0
0
Minority Interest
0
0
19
0
0
0
0
0
0
0
Other Liabilities
19
1
6
4
2
1
0
1
0
0
Total Liabilities
68
N/A
34
-51%
49
+45%
13
-73%
7
-47%
6
-9%
4
-44%
5
+37%
7
+35%
7
+1%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
291
372
405
382
398
417
426
453
507
528
Additional Paid In Capital
350
397
410
433
436
439
459
546
575
577
Treasury Stock
1
1
1
1
1
1
1
1
1
1
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
59
N/A
24
-59%
5
-79%
51
+931%
38
-25%
21
-45%
33
+56%
92
+184%
67
-28%
48
-28%
Total Liabilities & Equity
126
N/A
57
-55%
54
-6%
63
+19%
45
-30%
27
-39%
36
+32%
97
+169%
73
-25%
55
-25%
Shares Outstanding
Common Shares Outstanding
0
0
1
1
1
1
1
4
8
8
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More